Pharmafile Logo
Pharmafocus logo
Advanced Search
partnership

Unilab partners with TCS for cloud-led enterprise transformation

September 4, 2025

Tata Consultancy Services (TCS) has announced a partnership with Unilab, a pharma company based in the Philippines, to modernise its …

News

Accro Bioscience and Fosun Pharma sign licence deal for autoimmune therapy in Greater China

September 4, 2025

Accro Bioscience has granted Shanghai-based Fosun Pharma exclusive rights to develop, manufacture and commercialise its experimental therapy AC-201 in Greater …

News

Shaun Chilton appointed as hVIVO Non-Executive Chair

September 3, 2025

hVIVO, a full-service Contract Research Organisation (CRO) involved in human challenge clinical trials has announced that Shaun Chilton has joined …

Appointment

Vitalant and UPMC strengthen partnership in cell and gene therapy

September 3, 2025

Vitalant, a blood and biotherapies provider, is expanding its collaboration with the University of Pittsburgh Medical Center (UPMC), Pennsylvania, US, …

News

Craig Rhodes appointed as Qureight Head of Partnerships

September 2, 2025

Qureight, a techbio company, has appointed Craig Rhodes as Head of Partnerships to lead strategic engagements with pharmaceutical organisations. The …

Appointment

VITROCELL system aims to improve drug and particle safety testing

September 2, 2025

VITROCELL Systems has launched a new technology called Navetta to support researchers testing the safety of drugs and airborne particles …

News
FDA approves Moderna’s updated COVID-19 vaccines targeting new variant

FDA approves Moderna’s updated COVID-19 vaccines targeting new variant

September 1, 2025
FDA

The US Food and Drug Administration (FDA) has approved Moderna’s updated COVID-19 vaccines, Spikevax and mNEXSPIKE, intended to target the …

News
Lilly secures conditional MHRA approval for new blood cancer treatment

Lilly secures conditional MHRA approval for new blood cancer treatment

September 1, 2025

The UK’s Medicines and Healthcare products Regulatory Agency has granted conditional marketing authorisation for Eli Lilly’s pirtobrutinib (Jaypirca). This new …

News

Rare and severe epilepsies – current treatments and advance therapeutics

August 29, 2025
Medical Communications, Research and Development Neurology, UCB, epilepsy, epilepsy treatment, rare epilepsies

The current forms of immunotherapy, how T cell therapy works and what the future holds

Feature

Rotzinger launches modular filling and capping platform for over-the-counter products

August 29, 2025
Manufacturing Services, Manufacturing and Production Devices, Rotzinger PharmaPack, manufacturing and production

Rotzinger PharmaPack has launched a new filling and capping platform called VarioFill, designed to handle a wide range of over-the-counter …

News

Er-Kim to distribute CNX Therapeutics’ oncology drugs across Europe and Turkey

August 29, 2025
Logistics & Distribution, Manufacturing and Production, Mergers and Acquisitions CNX Therapeutics, Corporate, Er-Kim, Oncology, central nervous system disorders, critical care

Turkish pharma company, Er-Kim, has signed a distribution agreement with CNX Therapeutics to expand access to a portfolio of oncology …

News
hospital

The Pharma Files: With Professor Hatim Abdulhussein from Health Innovation Kent Surrey Sussex

August 28, 2025
Medical Communications, Research and Development Corporate, GP, Health Innovation Kent Surrey Sussex, The Pharma Files

Pharmafile chats with Priyanka Hinton, Customer Solutions Director at Chase People about the best parts of her job and her …

Feature

How pharma marketing needs to adapt as community pharmacies take centre stage

August 28, 2025
Business Services, Medical Communications, Sales and Marketing 10 Year Health Plan, Pharmacy, m3, pharmacy

The UK government’s 10-Year Health Plan is moving pharmacists to the frontline of primary care For decades, community pharmacies were …

Feature

European Commission approves HIV prevention injection

August 28, 2025
Medical Communications, Research and Development European Commission, Gilead Science, HIV, HIV/AIDS, US Food and Drug Administration, World Health Organisation

The European Commission (EC) has granted marketing authorisation for Gilead Science’s Yeytuo (lenacapavir), the first twice-yearly injectable medicine approved in …

News

EMA grants orphan drug designation for Roca’s treatment of radiation maculopathy

August 28, 2025
Medical Communications, Research and Development European Medicines Agency (EMA), Oncology, Opthalmology, Roca Therapeutics, maculopathy

The European Medicines Agency (EMA) has granted Orphan Drug Designation to Roca Therapeutics for its lead candidate RCT002, marking the …

News

The UK’s Life Sciences Sector Plan: a fresh launchpad or a continued labyrinth for the uptake of innovative medicines?

August 27, 2025
Business Services, Market Access, Market Access Consultancy, Sales and Marketing NHS, Visions4Health

As the UK healthcare system navigates a period of significant change, the path to successful market access is becoming increasingly …

Feature
Thought Leadership
handshake-2056023_960_720

Terumo to acquire Oxford spin-out OrganOx in $1.5b deal

August 26, 2025
Mergers and Acquisitions Corporate, OrganOx, Terumo, University of Oxford, organ transplantation

Japanese medical technology company Terumo has announced it will acquire OrganOx, a University of Oxford, UK, spin-out specialising in organ …

News

Neogap Therapeutics appoints Jonas Mattson to its board of directors

August 26, 2025
Research and Development Corporate, Immunology, Neogap Therapeutics, Oncology, board of directors

Swedish biotech, Neogap Therapeutics, has appointed Jonas Mattson, an authority in cell therapy, to its board of directors. His appointment …

Appointment
hsm_mobile_clinical_trial_istock-872676342

FDA approves Wegovy for treatment of MASH in adults with liver fibrosis

August 22, 2025
Medical Communications, Research and Development Hepatology, Novo Nordisk, US Food and Drug Administration, clinical trial, hepatitis, obesity

The US Food and Drug Administration (FDA) has granted accelerated approval for Wegovy (semaglutide) as a treatment for adults with …

News
johnsonsss

Johnson & Johnson commits $2bn to new manufacturing facility in North Carolina, US

August 22, 2025
Manufacturing and Production Corporate, Fujifilm, Johnson & Johnson

Johnson & Johnson has announced a $2bn investment in a new manufacturing facility in Holly Springs, North Carolina, US, expanding …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025